State Street’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
2022
Q3
$16K Hold
2022
Q2
$55K Buy
2022
Q1
$116K Buy
2021
Q4
$206K Hold
2021
Q3
$246K Hold
2021
Q2
$294K Sell
2021
Q1
$1.19M Buy
2020
Q4
$934K Sell
2020
Q3
$1.06M Buy
2020
Q2
$1.19M Buy
2020
Q1
$825K Buy
2019
Q4
$1.4M Buy
2019
Q3
$923K Buy
2019
Q2
$1.57M Buy